Tag: National Institute of Allergy and Infectious Diseases

New Drug Application for Remdesivir Submitted

Covid19August 19, 2020

The New Drug Application (NDA) for remdesivir (Veklury®; Gilead Sciences) has been submitted to the Food and Drug Administration (FDA) for the...

FDA halts COVID-19 blood plasma emergency approval

BiotechnologyAugust 19, 2020

As the FDA was prepping to allow emergency use of blood plasma donation from recovered COVID-19 patients, government officials have put pay to...

Fauci: Political pressure won’t interfere with FDA decisions on COVID-19 vaccines

BiotechnologyAugust 7, 2020

The FDA has vowed not to let political pressure to approve a COVID-19 vaccine as soon as possible interfere with the regulatory process,...

Fauci Reveals He Has Received Death Threats And His Daughters Have Been Harassed

Covid19August 5, 2020

Enlarge this image Dr. Anthony Fauci testifies last week in a House subcommittee hearing on...

Columbia team pinpoints potent antibody cocktail for COVID-19

BiotechnologyJuly 24, 2020

Scientists at Columbia University have identified a cocktail of antibodies they say could be a potent option for treating and preventing COVID-19. The...

Research Roundup: Progress on COVID-19 Vaccines and More

BiotechnologyJuly 23, 2020

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones. A Big Week for...

Moderna & NIAID’s Experimental COVID-19 Vaccine Found To Be Safe, Generates Immune Response

BiotechnologyJuly 15, 2020

According to interim results published online today in the New England Journal of Medicine, mRNA-1273, an investigational vaccine designed to protect against SARS-CoV-2, was found...

WHO Release New Guidelines On COVID-19 Airborne Transmission

BiotechnologyJuly 10, 2020

--Sharing is Caring-- After a few reports came out regarding the airborne transmission of the novel coronavirus, the World Health Organization has released...

Volunteers can now register for coronavirus disease vaccine trials

BiotechnologyJuly 10, 2020

As the world grapples with the coronavirus pandemic, many pharmaceutical companies, and research organizations are racing to develop an effective vaccine against the...

NIAID creates new COVID-19 drug and vaccine trial network through Trump’s Warp Speed program

BiotechnologyJuly 9, 2020

The National Institute of Allergy and Infectious Diseases (NIAID) is launching a new clinical trial network to seek out and add thousands of...

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

BiotechnologyJuly 8, 2020

Reviewed by Emily Henderson, B.Sc.Jul 8 2020 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH),...

COVID-19 Treatment By Regeneron Pharmaceuticals Enters Final Human Trials Stage

BiotechnologyJuly 7, 2020

--Sharing is Caring-- Regeneron COVID19 Drug REGN-COV2 EntersFinal Stage Trials of Human TrialsThe American biotechnology company, Regeneron Pharmaceuticals has been investigating a drug...

1...456...13 Page 5 of 13

Generative Data Intelligence

Tag: National Institute of Allergy and Infectious Diseases

Latest Intelligence

Data and safety review board reports how it monitored the COVID-19 vaccine trials

Lessons from the last pandemic point the way toward universal flu vaccines

La Jolla Institute for Immunology launches new global cancer immunology resource

Clinical Trial Evaluating Mixed COVID-19 Vaccine Schedules Begins

NIH launches clinical trial of universal influenza vaccine candidate

Study shows long-lived immunity after COVID-19

Lessons from teaching about the pandemic in real-time

Chat with us